Miller KD - Search Results

1

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.

Mosher CE, Secinti E, Li R, Hirsh AT, Bricker J, Miller KD, Schneider B, Storniolo AM, Mina L, Newton EV, Champion VL, Johns SA. Mosher CE, et al. Among authors: miller kd. Support Care Cancer. 2018 Jun;26(6):1993-2004. doi: 10.1007/s00520-018-4045-0. Epub 2018 Jan 12. Support Care Cancer. 2018. PMID: 29327085 Free PMC article. Clinical Trial.

2

Metastatic breast cancer: the role of chemotherapy.

Sledge GW Jr, Miller KD. Sledge GW Jr, et al. Among authors: miller kd. Semin Oncol. 1999 Feb;26(1 Suppl 2):6-10. Semin Oncol. 1999. PMID: 10190779 Review.

3

The role of chemotherapy for metastatic breast cancer.

Miller KD, Sledge GW Jr. Miller KD, et al. Hematol Oncol Clin North Am. 1999 Apr;13(2):415-34. doi: 10.1016/s0889-8588(05)70063-0. Hematol Oncol Clin North Am. 1999. PMID: 10363138 Review.

4

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.

Miller KD, Gradishar W, Schuchter L, Sparano JA, Cobleigh M, Robert N, Rasmussen H, Sledge GW. Miller KD, et al. Ann Oncol. 2002 Aug;13(8):1220-4. doi: 10.1093/annonc/mdf199. Ann Oncol. 2002. PMID: 12181245 Free article. Clinical Trial.

5

A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.

Miller KD, Soule SE, Haney LG, Guiney P, Murry DJ, Lenaz L, Sun SL, Sledge GW Jr. Miller KD, et al. Invest New Drugs. 2004 Jan;22(1):69-73. doi: 10.1023/b:drug.0000006176.84915.71. Invest New Drugs. 2004. PMID: 14707496 Clinical Trial.

6

A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.

Miller KD, Saphner TJ, Waterhouse DM, Chen TT, Rush-Taylor A, Sparano JA, Wolff AC, Cobleigh MA, Galbraith S, Sledge GW. Miller KD, et al. Clin Cancer Res. 2004 Mar 15;10(6):1971-5. doi: 10.1158/1078-0432.ccr-03-0968. Clin Cancer Res. 2004. PMID: 15041714 Clinical Trial.

7

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, Langmuir V, Rugo HS. Miller KD, et al. J Clin Oncol. 2005 Feb 1;23(4):792-9. doi: 10.1200/JCO.2005.05.098. J Clin Oncol. 2005. PMID: 15681523 Clinical Trial.

8

Angiogenesis of breast cancer.

Schneider BP, Miller KD. Schneider BP, et al. Among authors: miller kd. J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017. J Clin Oncol. 2005. PMID: 15755986 Review. No abstract available.

9

A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer.

Miller KD, Trigo JM, Wheeler C, Barge A, Rowbottom J, Sledge G, Baselga J. Miller KD, et al. Clin Cancer Res. 2005 May 1;11(9):3369-76. doi: 10.1158/1078-0432.CCR-04-1923. Clin Cancer Res. 2005. PMID: 15867237 Clinical Trial.

10

A physiologic imaging pilot study of breast cancer treated with AZD2171.

Miller KD, Miller M, Mehrotra S, Agarwal B, Mock BH, Zheng QH, Badve S, Hutchins GD, Sledge GW Jr. Miller KD, et al. Among authors: miller m. Clin Cancer Res. 2006 Jan 1;12(1):281-8. doi: 10.1158/1078-0432.CCR-05-0219. Clin Cancer Res. 2006. PMID: 16397053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters